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Abstract 
 
Degradation properties of a bi-layered cross-linked 
collagen membrane for localized bone regeneration:  
In vitro and in vivo study 
 
Jin-Young Park, B.D.S 
 
Department of Dentistry 
The Graduate School, Yonsei University 
 
(Directed by Professor Seong-Ho Choi, D.D.S., M.S.D., PhD.) 
 
Purpose: (i) To evaluate the biologic properties of a bi-layered EDC-cross-linked 
collagen membrane (CCM) in vitro. (ii) To assess the efficacy of CCM for localized bone 
regeneration in vivo. 
 
Methods: Biodegradation of CCM compared to a non-cross-linked collagen 
membrane (NCM) was assessed in vitro. In vivo, twelve male New Zealand White rabbits 
were used. Four calvarial, circular defects (diameter 8mm) were created in each animal. 
The sites were randomly allocated to i) CCM + biphasic calcium phosphate (BCP) 
  
v 
(CCM-BCP group), ii) CCM alone (CCM), iii) BCP alone (BCP) and, iv) negative 
control (control). Animals were sacrificed at 2 (n = 6) and 8 weeks (n = 6). Outcome 
measures included: micro CT analysis (total augmented volume (TAV), new bone 
volume (NBV)) and histomorphometry (total augmented area (TAA), newly formed bone 
(NBA), remaining membrane thickness (RMT)). 
 
Results: CCM was more resistant to degradation than NCM. Micro CT analysis 
showed CCM-BCP (196.43±25.30 mm3) and BCP (206.23±39.13 mm3) groups had 
significantly (P<0.01) larger TAV than the control (149.72 ± 12.28 mm3) after 8 weeks. 
Histomorphometrically, CCM-BCP group (17.75 ± 5.97 mm2) had significantly (P<0.01) 
greater TAA compared to the CCM group (7.74 ± 2.25 mm2) and the control (8.13 ± 1.81 
mm2) after 8 weeks. After 8 weeks, RMT was reduced by 67%.  
 
Conclusion: BCP is required for space maintenance in regeneration of a localized 
bone defect. The dense non-porous layer of the CCM was maintained after 8 weeks, 
whereas the porous layer was replaced by new bone or dense collagenous tissue. 
 
 
 
 
Key words: Bone regeneration; Biodegradation; Collagen; Hydroxyapatite-beta 
tricalcium phosphate 
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I. INTRODUCTION 
 
Guided bone regeneration (GBR) is a well-established procedure to regenerate an 
adequate ridge width for implant placement. Moreover, according to a recent study, the 
number of implants placed in conjunction with GBR is increasing 1. This serves as an 
indicator for the predictability of the procedure and the awareness of the clinicians to 
place implants in a restoration-driven position. The biologic principle of GBR is to place 
a barrier membrane over an osseous defect, in order to exclude the overlying epithelium 
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and connective tissues, and to create a secluded space for bone formation 2-4. 
Characteristics of an ideal barrier membrane include biocompatibility, cell occlusiveness, 
space maintenance, tissue integration and ease of handling.  
Numerous non-resorbable and resorbable barrier membranes have been introduced in 
the past. Clinically, the use of resorbable membranes for GBR of peri-implant defects 
resulted in stable long-term peri-implant marginal bone levels 5-7. However, due to a lack 
of stiffness, resorbable membranes need to be combined with a membrane-supporting 
(bone substitute) material to maintain the defect space 8. A rapid and sometimes 
unpredictable degradation rate is considered a further drawback of these membranes. This 
may result in an early loss of the barrier function prior to complete defect healing. 
In order to prolong the barrier function, collagen membranes have been applied pre-
clinically and clinically, in the cross-linked form 9, or in double layers 10-12. A previous 
study demonstrated good biocompatibility and enhanced regeneration of calvarial defects 
for a chemically cross-linked collagen membrane (CCM) 13. Recently, this barrier 
membrane was modified into a bi-layer form consisting of a dense, non-porous collagen 
film layer facing the connective tissues, and a porous collagen sponge layer facing the 
defect. It is considered that this new structure will result in enhanced bone regeneration 
by improving cell-occlusivity and extending the barrier function. 
The aim of the present study was (i) to characterize and evaluate the biocompatibility 
and degradation of CCM in vitro, and (ii) to assess the efficacy of CCM for localized 
bone regeneration in vivo.   
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II. MATERIALS AND METHODS 
 
1. Materials 
Bilayered cross-linked collagen membrane (CCM) 
The bilayered chemically cross-linked type-I collagen membrane (CCM) (Dalim 
Tissen co., Ltd., Seoul, Korea) is derived from porcine skin and is composed of type I 
collagen. The membrane features two layers: a compact non-porous film layer designed 
to prevent infiltration of soft connective tissue cells into the membrane-protected space; 
and (ii) a porous sponge layer, facing the bone defect and consisting of loosely arranged 
collagen fibers. The porous layer is intended to stabilize the blood clot and to enhance 
bone formation.  
 
Native collagen membrane (NCM) 
The native collagen membrane (NCM) (Biogide, Geistlich Biomaterials, Wolhusen, 
Switzerland) is derived from porcine dermis and is composed of type I and III collagen. 
The membrane has two layers and been characterized in numerous studies 11. 
 
Synthetic bone substitute 
The biphasic calcium phosphate (BCP; OsteonTM III, Genoss, Seoul, Korea) consists 
of 60% hydroxyapatite and 40% β-tricalcium phosphate (TCP). The bone graft particles 
were 0.5-1.0 mm in size with interconnected macro and micro pores.  
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2. Experiments 
In vitro 
Tensile strength test 
Dry samples of CCM and NCM of 30 x 5 mm in size were compared for tensile strength. 
The membranes were placed on a universal tensile machine and stretched at 10 mm/min 
until the point of breakage. The ultimate strength at the point of breakage was recorded 
three times, from which an average was deduced. 
 
Enzymatic degradation assay 
In vitro degradation test was performed using bacterial collagenase from Clostridium 
histolyticum (Sigma, Type I, 0.5-5.0 units/mg, 85.3 unit/ml). Collagenase was dissolved 
in 50 mM TES buffer (50 mM Tris, 5 mM EDTA, 2.5% sucrose) with 0.36 mM CaCl2, 
pH 7.4. Samples of CCM and NCM were weighed to obtain an initial dry weight (Wi) 
and immersed in 5 ml TES buffer containing 0.1 mg of collagenase for 4 h at 37 ℃. The 
remaining samples were collected, lyophilized, and weighed to obtain the dry weight after 
enzymatic degradation (Wd). The proportion of the remaining weight of the samples was 
defined as: remaining weight (%) = Wd/Wi X 100. 
 
Cytotoxicity test 
CCM, positive (latex film) and negative (polyethylene film) controls were extracted 
in 0.9% sodium chloride at 37 ℃ for 72 h. L-929, a mouse fibroblast cell line, was 
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cultured for 48 h in Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
bovine serum (FBS) and 1% antibiotic-antimycotic solution at 37 ℃ in a 5% CO2 
humidified incubator. The extracts were used to replace the maintenance medium of the 
cell culture. All cultures were incubated for 24 h, under the same growth condition as 
described above. After the incubation, each culture was stained with tetrazolium dye 
solution and lysed with dimethyl sulfoxide. Absorbance was measured at 570 nm with an 
automatic microplate reader. The relative cell viability was expressed as the percentage of 
the optical densities in the test medium to the fresh medium. 
 
In vivo 
Animals 
Twelve male New Zealand White rabbits weighing 2.8-3.2 kg and aged 16-20 weeks 
were used in this study. The sample size was determined from a previous study using the 
same experimental model. The animals were housed in separate cages under standard 
laboratory conditions with ad libitum access to water and a standard laboratory pellet diet. 
Animal selection and care, surgical protocol, and preparation followed routines approved 
by the Institutional Animal Care and Use Committee (Yonsei Medical Center, Seoul, 
Korea; approval number 2015-0072). The ARRIVE (Animal Research: Reporting of In 
Vivo Experiments) guidelines were referred to for the design and implementation of this 
study 14. 
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Surgical procedures (Figure 1) 
The surgical procedures were decribed in detail in a previous publication 15. In brief, 
an incision was made along the midline of the cranium from the frontal bone to the 
occipital bone in order to expose the calvarium. A full-thickness flap was elevated. Under 
copious saline irrigation, four standardized round defects, each 8 mm in diameter, were 
created using a trephine bur. The resected bone windows were removed carefully to avoid 
injury to the underlying dura mater and brain tissue. The defects were randomly assigned 
to the following four treatment modalities: 
 CCM-BCP: cross-linked collagen membrane plus biphasic calcium phosphate 
 CCM: cross-linked collagen membrane plus blood clot  
 BCP group: biphasic calcium phosphate only 
 Control group: filled with blood clot only 
In group CCM-BCP, the BCP particles were placed into the defect, then the CCM 
covered the entire site. In group CCM, blood was allowed to coagulate inside the defect, 
which was covered by the CCM. In group BCP, only the BCP particles were packed into 
the defect. In control, only the blood clot occupied the defect. 
For the groups containing BCP, the amount of BCP was standardized at 0.07-0.08 g to 
completely fill each defect by application of gentle pressure with a surgical instrument. 
For the groups covered by CCM, the membrane was cut to the size of 10 x 10 mm to 
cover the entire perimeter of defect. 
Subsequently, the flaps were repositioned and sutured. The sutures were removed one 
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week postoperatively. The animals were euthanized at 2 weeks (n = 6) or 8 weeks (n = 6) 
and specimens harvested. 
 
Outcome measures 
Micro-computed tomography analysis 
All harvested specimens were fixed in 10% formalin for 10 days and scanned with a 
micro-computed tomography (μCT) system (Sky-Scan 1173, SkyScan, Aartselaar, 
Belgium) at a resolution of 13.85 μm (130 kV, 60 μA). The scanned data set was 
processed in DICOM (Digital Imaging and Communications in Medicine) format, and the 
area of interest was reconstructed with On-Demand 3-dimensional (3D) software 
(Cybermed, Seoul, Korea). The overall dimensional topography of the calvaria and the 
grafted sites were visualized in 3D reconstructed images. The ROIMC for the total 
augmented volume was defined by the outline of the circular defect margin, laterally; 
connective tissue border, superiorly; and the dura mater, inferiorly. For detailed analysis 
of augmented volume, all sectioned images were processed with NRecon 1.6.9.8 
reconstruction software (SkyScan). 2240 x 2240 pixel images were acquired for creation 
of cross-sections and analysis of bone formation. Radiopaque areas were distinguished 
from the total augmented area according to specific 8-bit threshold grayscale values. The 
gray-scale values were set from 120 to 255 for bone substitute and 72 to 120 for newly 
formed bone. Areas with grayscale values lower than 72 were considered as fibrovascular 
tissue. Within the ROIMC, the following parameters were measured: 
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 Total augmented volume (TAV; mm3): entire augmented volume. 
 New bone volume (NBV; mm3): volumetric measurement of the newly formed 
bone within the defect. 
 Residual graft volume (RGV; mm3): volumetric measurement of the remaining 
graft particles. 
 
Histologic and histomorphometric analysis 
The fixed specimens were decalcified in 5% formic acid for 14 days and then 
embedded in paraffin. Serial 5μm thick sections were cut through the central portion of 
each experimental site. Only sections located at the middle of the defects were selected, 
and stained with hematoxylin and eosin and Masson trichrome. The histologic slides were 
observed and digitally captured under a light microscope (DM LB, Leica Microsystems, 
Wetzlar, Germany) equipped with a camera (BX50, Olympus, Tokyo, Japan). After the 
conventional microscopic examination assessing the various tissues (bone, bone 
substitute material, non-mineralized tissue, membrane), computer-assisted histometric 
measurements in the calvarial defect were performed using an automated image analysis 
system (Image-Pro Plus; Media Cybernetics, Silver Spring, MD). The ROIH was defined 
by the margins of the original bone, laterally; the periosteum or the CCM, superiorly; and 
the dura mater, inferiorly. The following parameters were measured within the ROIH: 
 Total augmented area (TAA): This consists of the sum of the area of new bone, 
residual particles, fibrovascular tissues within the ROIH. 
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 New bone area (NBA): Area of newly formed bone within the ROIH. 
 Residual particle area (RPA): Area of the remaining bone graft particles within 
the ROIH. 
 Remaining membrane height (RMH): Height of the CCM measured at 3 
different points of the defect; left, middle and right. 
 
3. Statistical analysis 
The statistical analysis was performed using a commercially available software 
program (IBM SPSS Statistics 23). Micro-CT measurements and histomorphometric 
records were summarized in terms of the mean and standard deviation (SD) values. The 
relationship between the measured parameters and each of the factors was examined 
using the Kruskal-Wallis test (for factors with more than two levels) and Mann-Whitney-
U test (for factors with two levels). Wilcoxon Rank test was used to compare the same 
experimental group between the two time periods (2 and 8 weeks). Statistical significance 
was considered when P<0.05. 
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III. RESULTS 
 
1. In vitro 
SEM imaging (Figure 2) 
The thickness of CCM was measured at 350 m, the dense non-porous layer was 25 
m, and the spongy porous layer was 325 m. The pore size of the spongy layer was 
approximately 20 m. Thin sheets of collagen structures were arranged in a lattice shape 
to form the porous layer of CCM. The dense portion had a smooth surface with no pores. 
The surface of the dense film layer appeared smooth even at a very high magnification 
(x1000). 
 
Tensile strength test 
The results showed that the CCM (5.22  0.1 N/mm2) and NCM (5.1  0.1 N/mm2) 
had similar mechanical strengths. 
 
Enzymatic degradation assay 
After 4 h of degradation by bacterial collagenase, the remaining sample weight of 
CCM (43.09  0.05%) was significantly greater than that of NCM (13.46  0.08%). 
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Cytotoxicity test 
The relative cell viability was comparable between CCM (99.74  2.7%) and the 
negative control (polyethylene, 100  2.1%). These values were significantly greater than 
that of the positive control (latex, 2.15  0.38%) 
 
2. In vivo  
Although 3 of the animals had slight tearing of the dura mater during surgery, 
postoperative complications such as swelling and bleeding were at low levels and no 
signs of infection or abnormal appearances could be detected. All animals remained 
healthy throughout the entire experimental period. Wound healing was uneventful. 
 
Micro CT analysis 
The results of the micro CT analysis are summarized in Table 1. In the 3D 
reconstructed view, BCP particles were well-contained by the CCM in the CCM-BCP 
group, whereas in the BCP group, scattering of the BCP particles was frequently seen 
(Figure 3). Cross-sectional view of each group at both time points are represented in 
Figure 4. 
At 2 weeks, the CCM-BCP group showed the highest total augmented volume (TAV) 
(222.32 ± 80.41 mm2), but there was no significant difference compared to controls 
(P=0.369). The CCM-BCP group (34.37 ± 11.04 mm3) also demonstrated the highest new 
bone volume (NBV) when compared to the control (6.7 ± 6.46 mm3; P=0.000) and the 
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CCM group (13.80 ± 9.79 mm3, P=0.004). NBV was significantly greater (P=0.006) in 
the BCP group (26.91 ± 5.71 mm3) than in the control group (6.7 ± 6.46 mm3). 
At 8 weeks, CCM-BCP and BCP groups had significantly higher TAV than the control 
group. However, in terms of the NBV, there was no significant difference between the 
four groups. The remaining material volume (RMV) showed a slight decrease from 2 
weeks (CCM-BCP group, 17.77 ± 3.41 mm3; BCP group, 15.06 ± 3.29 mm3) to 8 weeks 
(CCM-BCP group, 17.38 ± 6.42 mm3; BCP group, 13.63 ± 5.06 mm3).  
 
Descriptive histology 
CCM-BCP group 
At 2 weeks, the defect spaces were well-augmented and BCP particles well-contained 
below the CCM membrane (Figure 5A). The CCM maintained an unfragmented barrier. 
Callus-like woven bone was found in abundance, and started to proliferate from the 
periphery of the defects. At 8 weeks, although all defects were not completely repaired, 
woven bone was replaced by dense lamellar bone. Lamellar bone had a tendency to form 
clusters around the BCP particles (Figure 6A). Evidence of intramembranous neo-
ossification was seen in most of the specimens. In one of the specimens in particular, the 
porous layer of CCM was completely replaced by a sheet of mature lamellar bone, and 
covered the cranial part of the defect (Figure 6A). 
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CCM group 
At 2 weeks, membranes maintained the original thickness and shape (Figure 5B). The 
dense film layer could be distinguished from the porous sponge layer (Figure7). Newly 
formed bone was found extending from the native bone. 
At 8 weeks, in the majority of the specimens, almost complete closure of defect was seen 
(Figure 6B). In general, the porous layer was mostly resorbed, whereas the dense layer 
remained. In two of the specimens, formation of blood vessels could be seen within the 
dense collagen film layer (Figure 7). 
 
BCP group 
At 2 weeks, direct apposition of new bone onto the porous structure of the BCP 
particles could be observed (Figure 5C). At 8 weeks, new bone formation seemed to 
occur in small clusters around BCP particles as focal points, rather than forming a 
continuous layer from the periphery (Figure 6C). Less particles occupied the defect 
compared to the CCM-BCP group. 
 
Control 
At 2 weeks, minimal new bone formation was observed (Figure 5D). In general, the 
defect spaces were filled with underlying brain tissues. At 8 weeks, new bone formation 
originating from the periphery reached further into the center of the defect. In part 
lamellar bone formation was observed (Figure 6D). 
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Histomorphometrical analysis 
The results of the micro histomorphometrical analysis are summarized in Table 2. At 
2 weeks, the CCM-BCP group had the highest total augmented area (TAA) (15.78±4.63 
mm2), when compared to the control (8.13 ± 1.81 mm2) and the CCM group (7.74 ± 2.25 
mm2) (P=0.009, 0.002 respectively). CCM group also showed significantly higher TAA 
compared to the control group (P=0.009). 
At 8 weeks, CCM-BCP group (17.75±5.97 mm2) had a significantly higher TAA 
compared to the CCM (9.23 ± 2.91 mm2) and control groups (3.7±0.76 mm2) (P=0.004, 
0.004), but not to the BCP group (13.93 ± 2.29 mm2) (P=0.792). 
Measurements for the area of newly formed bone (NBA) revealed significantly higher 
values for CCM-BCP (2.15±0.99 mm2) and CCM (2.43±0.29 mm2) compared to the 
control group (1.12±1.92mm2) (P=0.004, 0.03 respectively) at 2 weeks. 
The height of the membranes (RMH) in the CCM-BCP and CCM groups decreased 
between 2 weeks (0.28 ± 0.55 mm) and 8 weeks (0.18 ± 0.12 mm).  
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IV. DISCUSSION 
 
This study revealed that the combined use of a membrane and bone substitute 
particles (CCM-BCP) resulted in the highest total augmented area based on 
histomorphometry. In vitro, CCM demonstrated a significantly higher resistance to 
degradation compared to a native collagen membrane. In vivo data, indicated, however, 
that the membrane underwent degradation process predominantly of the spongeous layer 
and the dense layer remained up to 8 weeks.  
The CCM-BCP group in this study showed the greatest augmented area, although 
the difference between the CCM-BCP and BCP groups did not reach a statistical 
significance. Nonetheless, micro CT images showed that there was less scattering of the 
bone substitute particles in the CCM-BCP group compared to BCP group. These results 
indicate that bone substitute is needed to gain graft volume, and CCM may help to 
stabilize the graft by preventing scattering of the particles. It is well known that 
hydrated collagen membrane lacks structural rigidity, therefore, bone substitute material 
is required to support the membrane 16. In a systematic review, the combined approach 
of a particulated bone substitute and collagen membrane was the most widely used 
method for guided bone regeneration in localized bone defects 17. A study in the rat 
calvarial defect model utilized different combinations of native collagen membrane, 
deproteinized bovine bone mineral (DBBM), and enamel matrix derivative 18 for GBR. 
The results after 4 months revealed that the presence of barrier membrane increased the 
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rate of complete defect closure, however, the regenerated bone had a concave 
appearance due to membrane collapse. The use of DBBM resulted in increased 
thickness of calvaria but DBBM particles were consistently encapsulated by loose 
fibrous tissue even when membrane was used. Likewise, in the current study, the use of 
BCP did not result in significant increase in NBA/NBV after 8 weeks, which confirms 
that its role is confined to support and provision of space under membrane. Furthermore, 
the use of a membrane only (CCM group) was not able to maintain space, and the TAV 
was significantly less compared to the bone grafted groups (BCP, CCM-BCP groups). 
When interpreting this result, it should be noted that the membrane was placed only 
over the top of the defect, which cannot prevent the underlying brain tissue from 
invading the defect space. 
Sustained barrier function for up to 6 months 3,4,12,19 and space maintenance 18 are 
reported to be key elements for successful GBR. This study revealed that CCM was 
more resistant to degradation than a native collagen membrane in vitro. In vivo, the 
dense film layer of CCM remained intact up to 8 weeks, whereas the porous sponge 
layer was substituted by newly formed bone or dense collagenous tissue. Similar 
attempts have been made previously to improve the bio-durability of collagen 
membranes. A study in the rabbit calvaria also applied a porcine-derived native 
collagen membrane (NCM) in a double layer for onlay graft 10. They reported that a 
single layer disappeared completely after 4 months, whereas a double layer sustained 
barrier function after 6 months and produced better bone mineralization density. In 
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another study in rat calvarial defect model, NCM was also applied in double layers 11. 
They found remaining collagen area was greater in the double layer than the single 
layer. The NCM itself is a bi-layered membrane consisting of a compact layer and a 
porous layer, which are designed to serve the same purposes as the CCM in this study. 
Considering that a single layer of NCM underwent 30% reduction in thickness over a 5 
week period (between 4 and 9 weeks), CCM might be more susceptible to degradation 
in vivo (67% reduction in thickness between 2 and 8 weeks). Nevertheless, only the 
porous sponge layer of CCM appeared to undergo biodegradation, whereas the dense 
film layer remained intact. The slow degradation of the dense layer appears to be 
accompanied by limited tissue integration, and is observed by the split separating the 
membrane from adjacent connective tissue. This separation could have been enhanced 
as a result of histologic processing and weak attachment of the connective tissue to the 
surface. The dense film layer may be speculated to retain its cell-occlusivity, as it 
appears to maintain the continuous outline histologically.  
Although the bone filler in this study was able to maintain the graft volume after 8 
weeks, there has not been a significant increase in new bone. This could be explained by 
the slow rate of graft degradation and large amount of residual particles still occupying 
the defect after 8 weeks. -TCP is known to undergo fast resorption and replacement by 
new bone, whereas HA is more resilient and provides osteoconductivity. The HA: -TCP 
ratio of 60:40 was utilized in this study, and the rate of degradation was comparable to the 
reports of other studies 15,20,21. Materials with slow degradation rate can be more suitable 
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for challenging defect sites that takes longer time to regenerate, for example, onlay grafts 
and vertical augmentation. However, in self-containing defects such as the present study, 
a greater -TCP content may be preferred.  
Biocompatibility of the crosslinked collagen membrane has been a cause for concern 
in the recent literature. Certain crosslinking agents such as glutaraldehyde are known to 
evoke tissue reaction as a byproduct of enzymatic degradation 22,23. A previous clinical 
trial demonstrated more frequent incidence of membrane exposure with cross-linked 
collagen membranes 24, and transmembraneous angiogenesis, which is supposedly 
beneficial for osteogenesis, was prevented until 24-weeks in an enzymatically cross-
linked membrane 25. In addition, an increase in the degree of cross-linking was inversely 
related to tissue integration in a study in rats 26. The collagen membrane in the present 
study was chemically cross-linked using EDC, which has been shown to be safe to use in 
vitro 27,28 and in animal studies 13. In contrast to other chemical agents such as 
glutaraldehyde or polypeptide, EDC does not remain as a part of the cross-linkage after 
degradation but simply change to water-soluble urea derivatives that have very low 
cytotoxicity 28. In vitro analysis of the present study showed high cellular compatibility, 
and no complications in terms of membrane exposure and abnormal tissue reaction were 
observed in vivo. Transmembraneous angiogenesis, which has been reported to be 
hindered in cross-linked collagen membranes, showed to take place at 8 weeks in the 
dense film layer of the CCM. Furthermore, it is noteworthy that in the 8-week specimens, 
intra-membrane neo-ossification could be observed in the porous layer of the CCM. In 
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one of the specimens, the porous layer was nearly completely replaced by a sheet of new 
bone, which suggests that the current membrane has excellent tissue integration and 
biocompatibility. These results propose that the EDC-crosslinked collagen membrane has 
the potential for enhanced performance with a better structural design than the current one. 
An interesting suggestion in a study using NCM 11 was that the main pattern of resorption 
was internal and not external, which can be related to the transmembraneous angiogenesis 
of NCM 25. A second layer of cross-linked collagen membrane on top of NCM may 
compensate for the disadvantage of each membrane, while enhancing the longevity of 
barrier function. 
There are some limitations to this study. Firstly, there was no in vivo comparison 
between CCM and NCM, although the two materials were compared in vitro. Secondly, 
the sample size was too small to reach rigid statistical power. The sample size of the 
current study was based on previous experiments carried out on the same experimental 
model. However, sample size calculations based on the results from this study revealed 
that ideally, 30 animals should be used to reach a statistical value. Thirdly, in the CCM 
group, the membrane was applied over the top of the defect, but the brain tissue below 
often bulged into the defect space, especially if the dura mater was torn during 
preparation of defect. Therefore, ideally, the membrane should be placed on both sides of 
the defect to properly assess the space maintaining ability. 
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V. CONCLUSION 
 
In conclusion, CCM has better resistance to enzymatic degradation than natural 
collagen membrane, in vitro. In vivo, the presence of bone substitute particles enhances 
the regeneration of a localized bone defect by maintenance of defect space. The dense 
non-porous layer of the CCM was maintained after 8 weeks, whereas the porous layer 
was replaced by new bone or dense collagenous tissue. 
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TABLES 
 
Table 1. Results from the micro CT analysis.  
 
  TAV NBV RMV 
2 weeks 
CCM-BCP 222.32 ± 80.41 *†34.37 ± 11.04 17.77 ± 3.41 
CCM 186.55 ± 66.9 13.80 ± 9.79 
 
BCP 186.33 ± 38.32 *26.91 ± 5.71 15.06 ± 3.29 
Control 151.68 ± 29.91 6.7 ± 6.46   
8 weeks 
CCM-BCP *196.43 ± 25.30 38.43 ± 7.22 17.38 ± 6.42 
CCM 166.02 ± 30.38 23.73 ± 5.4 
 
BCP *206.23 ± 39.13 34.61 ± 13.96 13.63 ± 5.06 
Control 149.72 ± 12.28 22.83 ± 10.56  
Values are presented as mean±standard deviation 
* Statistically significant difference compared to the control group. 
† Statistically significant difference compared to the CCM group. 
TAV=total augmented volume; NBV=new bone volume; RMV=remaining material 
volume. 
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Table 2. Results from the histomorphometric analysis. 
    TAA NBA RPA RMH 
2 weeks 
CCM-BCP *†15.78 ± 4.63 2.15 ± 0.99 3.44±0.88 0.58 ± 0.28 
CCM *9.23 ± 2.91 2.69 ± 2.07 
 
0.52 ± 0.21 
BCP *13.93 ± 2.29 1.27 ± 0.58 3.52±0.5 
 
Control 3.7 ± 0.76 1.12 ± 1.92   
8 weeks 
CCM-BCP *†17.75 ± 5.97 3.79 ± 2.62 3.49±0.85 ¶0.14 ± 0.13 
CCM 7.74 ± 2.25 2.43 ± 0.29 
 
¶0.17 ± 0.13 
BCP *15.09 ± 2.44 3.92 ± 1.25 3.44±0.68 
 
Control 8.13 ± 1.81 2.76 ± 1.28   
Values are presented as mean±standard deviation. 
* Statistically significant difference compared to the control group. 
† Statistically significant difference compared to the CCM group. 
¶ Statistically significant difference compared to the corresponding groups at 2 weeks. 
TAV=total augmented volume; NBV=new bone volume; RMV=remaining material 
volume. 
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FIGURES 
 
 
Figure 1. Experimental design in the rabbit calvarium. 
 
(A) Four circular defects 8 mm in diameter were prepared using trephine bur. (B) Each 
defect was assigned to an experimental group. Clockwise from top left; negative control, 
BCP, CCM-BCP and CCM. 
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Figure 2. SEM images of the bilayer EDC-cross-linked type-I collagen membrane 
(CCM).  
 
(A) Cross-sectional view of the CCM showing the porous sponge layer (left) and the 
dense film layer (right). (Dotted line=100 μm) (B) The surface of the porous layer. 
(Dotted line=300 μm). (C) The smooth surface of dense film layer showing no pores 
(Dotted line=30 μm). 
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Figure 3. 3-dimensional reconstructed radiographic views of the defects after 2 
weeks (A), and 8 weeks of healing (B).  
 
Scattering of the BCP particles can be observed in the BCP group, whereas BCP is 
contained within the defect in the CCM-BCP group.  
  
  
- 31 - 
 
 
 
Figure 4. Color coded cross-sectional radiographic view of the defects at 2 and 8 
weeks. 
 
Bone is shown in purple, bone substitute particles are shown in yellow-blue. New bone 
formation occurred mainly at the defect periphery in the control group. The original 
volume of the cranial bone before defect preparation is maintained with CCM-BCP and 
BCP groups. 
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Figure 5. Histological images obtained at 2 weeks.  
(A-D) Low magnification views of the groups CCM-BCP, CCM, BCP, and control, 
respectively (Masson Trichrom, bar=1 mm). (E-H) High magnified views of each 
highlighted area (H&E, bar=500 μm). (E) CCM appears to maintain the original shape. (F) 
The porous layer is integrated and adapted to the defect margin without any adverse 
reactions. (G) The pores of the BCP are beginning to fill with woven bone structures. (H) 
Woven bone formation in island produced by the overlying periosteum. The defect 
margins are labeled with arrowheads. NB=new bone, BCP=biphasic calcium phosphate, 
PL=porous layer, DL=dense layer.  
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Figure 6. Histological images obtained at 8 weeks.  
 
(A-D) Low magnification views of the groups CCM-BCP, CCM, BCP, and control, 
respectively (Masson Trichrome, bar=1 mm). (E-H) High magnified views of each 
highlighted area (H&E, bar=500 μm). (E) The dense layer is remaining after 8 weeks, 
whereas the porous layer has been replaced by a sheet of new bone. (F) Porous layer 
shows integration with connective tissue matrix that can be expected to turn into bone 
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tissue after a longer healing period. The dense layer remains unresorbed and provides 
protection over the top. (G) BCP particles at the top middle aspect of the defect are 
surrounded by newly formed bone, which displays good osteoconductivity of the bone 
substitute material. (H) Bony islands in the control group without much defect closure. 
The defect margins are labeled with arrowheads. NB=new bone, BCP=biphasic calcium 
phosphate, PL=porous layer, DL=dense layer. 
 
 
 
Figure 7. High magnification view of the CCM after 8 weeks, showing the dense 
layer (DL) and the porous layer (PL).  
 
Penetration of blood vessels (arrows) can be seen within the membrane. (Masson 
Trichrome, bar=100 μm) 
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국문요약 
 
국소적 골 재생 술식을 위한 가교화된 이중층 콜라겐 
차폐막의 분해 성질: In vitro and in vivo study 
 
 
<지도교수 최 성 호> 
연세대학교 대학원 치의학과 
박 진 영 
 
골 재생 술식에 사용되는 이상적인 차폐막은 생체적합성, 세포 차단성, 공간 
유지성, 조직 친화성과 같은 다양한 성질을 필요로한다. 따라서 비흡수성과 
흡수성 차폐막에 해당되는 다양한 소재의 차폐막들이 과거에 소개되었왔다. 
이중 흡수성 콜라겐 차폐막은 생체적합성이 우수하고 제거를 위한 이차 수술
이 필요하지 않기 때문에 현재 가장 널리 사용되고 있다. 하지만 콜라겐은 체
내에서 빠르고 예측하기 힘든 속도로 분해되어 골 결손부의 완전한 치유가 일
어나기 전에 차폐막의 기능이 소멸된다. 차폐막의 기능을 더 오래동안 유지하
기 위한 방법으로는 콜라겐의 분해를 지연시키기 위한 콜라겐의 가교화나 막
의 이중층 적용을 들 수 있다. 본 연구의 목적은 가교화된 이중층 콜라겐 차
폐막을 이용하여 (1) 생체외에서 생체적합성과 흡수속도를 평가하고, (2) 생체
내에서 국소적 골 재생 술식을 시행하였을 때 효능을 평가하는 것이다. 
생체외에서 효소 분해 실험을 통해 가교화된 콜라겐 차폐막(CCM)과 자연적 
콜라겐 차폐막의 분해 속도를 비교하였다. 생체내 실험에는 12마리의 토끼
(New Zealand White; 남성)가 사용되었다. 각각의 토끼 두개골에 4개의 직경 
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8 mm 골 결손부를 형성하여 4개의 군을 적용하였다; (1) CCM과 합성골이식
재(BCP)군 (CCM-BCP), (2) CCM만 적용한 군 (CCM), (3) BCP만 적용한 군 
(BCP), (4) 비어있는 대조군. 동물들은 2주와 8주에 여섯마리씩 희생되었다. 
결과의 계측을 위해 micro CT 분석(총 증강된 부피 (TAV), 신생골 부피
(NBV)) 그리고 조직학적 계측(총 증강된 면적 (TAA), 신생골 면적 (NBA), 
잔존 차폐막의 두께 (RMT))을 시행하였다. 
생체외에서 CCM은 자연적 콜라겐 차폐막보다 분해에 대해 더 큰 저항력을 
가지고 있었다. Micro CT 분석을 통해 개개의 실험 군에 대한 TAV를 계측했
을 때, 8주 째에 CCM-BCP군 (196.43±25.30 mm3)과 BCP군(206.23±39.13 
mm3)이 대조군(149.72 ± 12.28 mm3)보다 통계적으로 유의차있게 큰 결과를 
보였다. 조직학적인 분석을 통해 TAA를 계측했을 때, 8주 째에 CCM-BCP군이 
CCM군과 대조군보다 유의차있게 큰 결과를 보였다. 8주 후에 RMT는 67% 
가량 감소되었다. 
가교화된 이중층 콜라겐 차폐막을 이용한 국소적 골 재생 술식에서 골 이식
재의 사용은 공간 유지성을 확보하기 위해 필수적이다. 이중층 차폐막 상부의 
고밀도 층은 8주 후에도 유지가 되는 반면 하부의 다공성 층은 흡수되어 신
생골이나 dense한 결합조직으로 대체되었다. 
 
 
 
 
 
핵심되는 말: 골 재생, 생체 흡수, 콜라겐, 합성골 
